Is eylea the same as aflibercept?
Eylea generic A generic drug is an exact copy of the active drug in a brand-name medication. Eylea contains the active drug aflibercept. (As the active drug, aflibercept is the ingredient that makes Eylea work.) Aflibercept is also available as the brand-name drug Zaltrap.
What company owns eylea?
Regeneron maintains exclusive rights to EYLEA in the United States . Bayer HealthCare owns the exclusive marketing rights outside the United States , where the companies will share equally the profits from any future sales of EYLEA.
What drug company makes eylea?
EYLEA® (aflibercept) Injection by Regeneron.
What is aflibercept injection?
Aflibercept injection is used to treat wet age-related macular degeneration (AMD; an ongoing disease of the eye that causes loss of the ability to see straight ahead and may make it more difficult to read, drive, or perform other daily activities).
How quickly does Eylea work?
People who participated in clinical trials of Eylea (aflibercept) usually had improvements in their vision, or no further loss of vision, soon after starting the drug — in most cases within four weeks of receiving the first injection.
What happens if I stop Eylea injections?
If you stop the injections, you increase the risk of regrowth of abnormal blood vessels. Over the span of weeks to months, you may lose your central vision permanently.
Does Bayer make EYLEA?
Bayer/Regeneron’s Eylea (aflibercept) is a fusion protein that is used to treat retinal diseases such as wet age-related macular degeneration (wAMD), proliferative diabetic retinopathy (PDR), and diabetic macular edema (DME).
Does Bayer own Regeneron?
Under the terms of the agreement, Bayer HealthCare will make an upfront payment of $25.5 million to Regeneron and will share global development costs for the program.
Does Bayer make Eylea?
How is aflibercept used?
Aflibercept works by changing the amount of blood that gets to the retina. Aflibercept injection is also used to treat macular edema after retinal vein occlusion. It is also used to treat diabetic macular edema (DME) and diabetic retinopathy. Macular edema is swelling in the back of the eye and may cause vision loss.
Is aflibercept a chemotherapy drug?
Aflibercept (pronounced ay-flib-er-set) is a targeted cancer drug and is also known by its brand name, Zaltrap. It is a treatment for advanced bowel cancer. You usually have it together with the chemotherapy combination FOLFIRI. And only if you have already had the chemotherapy drug oxaliplatin.
Can I drive after eylea injection?
To be safe, don’t drive after receiving an Eylea injection. Only drive or use machinery when your vision is back to normal and it’s no longer blurry. Be sure to tell your doctor right away if you have symptoms of endophthalmitis.
What are Bayer and Regeneron doing with Eylea?
Both Bayer and Regeneron intend to seek approval for that indication. A few weeks later, Eylea won European approval in patients with macular degeneration due to central retinal vein occlusion, setting it up for another head-to-head battle with Lucentis (marketed by Novartis in Europe).
How can I get help with my Eylea costs?
If you have government insurance (like Medicare) and need help with your EYLEA out-of-pocket costs, Alternate Coverage Referral† may be available. The Patient Assistance Program may help eligible patients get EYLEA free of charge if you are uninsured or if your health plan doesn’t cover EYLEA. *Subject to annual assistance limit.
How much does Lucentis cost compared to Eylea?
Second, it cost less than the Roche drug. Regeneron ($REGN) priced Eylea at $1,850 per dose, compared with $2,000 for Lucentis.
What was the first year of Eylea sales?
Eylea – Regeneron and Bayer HealthCare. Eylea (aflibercept) Regeneron Pharmaceuticals and Bayer HealthCare. Launch Date: November 2011 (U.S., Regeneron); November 2012 (EU, Bayer) First-Year Sales: $838 million (2012, Regeneron); €14 million (partial 2012, Bayer) First-Half 2013 Sales: $643.7 million (Regeneron); €122 million (Bayer)